01 July 2019 – Grab Boosts Series H Round to $4.8bn

Big Ones

Southeast Asian ride hailing service Grab has boosted an already swelling series H round to $4.8bn, taking in $300m from investment management firm Invesco.

Deutsche Telekom Capital Partners was launched by its parent company nearly five years ago, and has now formed a $350m second venture and growth capital fund.

Who says the IPO market is on the dip? Adaptive Biotechnologies – backed by Microsoft, Celgene, Illumina, LabCorp and BD Biosciences – saw its share price double on its first day of trading – from $20 to $40.30 – while BridgeBio Pharma, which is developing drugs to treat diseases driven by genetic defects, floated above its range despite increasing the number of shares in its offering by a third.

On GUV, Commonwealth Fusion Systems (CFS), a US-based fusion power technology spinout of Massachusetts Institute of Technology (MIT), has closed a $115m series A round backed by MIT’s The Engine.

Deals

SpaceX is reportedly looking to raise more than $314m in its forthcoming round, with most or potentially all of it set to come from Ontario Teachers’ Pension Plan, which has confirmed it has invested in the GV-backed space services provider.

Ouyeel, an online trading platform spun off by China Baowu Steel, has raised $294m in a round featuring corporates Sinotrans, Benxi Group and Beijing Jianlong Heavy Industry as well as Baowu itself together with its Baoshan Iron and Steel subsidiary.

Digital manufacturing technology producer Carbon has received more than $260m in a round that pushed its overall funding past $680m.

Digital bank operator Monzo is going from strength to strength, helping to indicate that the UK’s Brexit woes have not affected its status as a centre of fintech.

StockX, the operator of an online marketplace for authenticated rare fashion items, has shown once again that the upmarket fashion space is an attractive one for investors. It has notched up $110m in a series C round featuring GV, which participated as an existing backer, at a valuation of more than $1bn.

Cardiac imaging technology provider Acutus Medical has secured $100m in series D funding from investors including GE Ventures as part of a larger round that included a $70m credit facility. Acutus has now raised roughly $230m in equity financing altogether, with GE Ventures having been an investor since at least 2013, and the funding will go to strengthening its atrial access product range.

Funds

That model of corporate venturing looks like it’s gaining some traction. Logistics services provider JD Logistics was spun off by e-commerce company JD.com two years ago but it is now getting into the corporate venturing game itself and has accumulated $218m for a strategic fund.

Exits

Fast fashion retail brand Miniso raised its first outside funding just eight months ago, having launched in 2013, but it is reportedly now gearing up for an initial public offering that could raise $1bn.

Upmarket fashion marketplace TheRealReal, proving it isn’t just the biotech sector that’s doing well, also completed a $300m initial public offering and went public on Friday.

Slack’s direct offering has pulled in the headlines but Stoke Therapeutics held its own successful listing last week, which it has now closed at just over $163m.

Atreca is working on immunotherapeutics to treat cancer, and raised $125m when it floated today, having priced the IPO at the midpoint of its range.

Velodyne Lidar is meanwhile pushing to become the first lidar technology developer to go public, having hired banks to underwrite an IPO expected to value it at about $1.8bn.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0

08 October 2018 – Grab Looking To Raise Another $1bn

Deals

Southeast Asian ride hailing platform Grab closed $2bn in funding just two months ago, but Reuters has reported that it’s looking to raise another $1bn, and that SoftBank is close to putting up half the funding.

SoftBank Vision Fund has also initiated talks to invest $500m in China-based online educational assistance platform Zuoyebang.

Traveloka, an Indonesian company that has grown into a leading holiday and travel services booking platform for Southeast Asia, is in talks with unnamed investors to raise $400m.

Elsewhere in Asia, SoftBank is reportedly in talks to invest between $200m and $250m in India-based Delhivery, one of several companies that have sprung up to feed the rapidly expanding e-commerce sector.

Enterprise cybersecurity software provider Tanium has secured $200m in a round led by Wellington Management that valued it at $6.5bn pre-money. Tanium, whose investors include Citi Ventures, has now raised about $780m altogether, and has amped up its valuation by some $1.5bn in just five months, the company having raised $175m from TPG Growth in a May round that valued it at $5bn.

Tencent and KKR’s KKR Asian Fund III have agreed to lead a $175m investment in Voyager Innovations, a fintech spinoff from telecommunications firm PLDT.

Fast fashion retailer Miniso was only founded in 2013 but has been growing at a rocket-like pace, currently standing at some 3,000 branches worldwide. Now Tencent is getting in on the act, joining Hillhouse Capital to provide $146m in funding for the company.

Education app developer Byju’s is now valued at $2bn following a $100m investment by General Atlantic India. Byju’s has raised a total of $344m from investors including Times Internet and Tencent, but the round is perhaps notable for not including SoftBank, which was said to be in talks with the company a couple of months back.

Call centre software provider Talkdesk closed a $21m series A round backed by Salesforce three years ago, but has taken a bug step forward with a $100m series B round that valued it at more than $1bn.

JHL Biotech has raised an undisclosed sum from investors including Sanoft at a $750m valuation and will put the cash toward further development of its biosimilar cancer therapies.

Drawbridge Health, a US-based medical diagnostics spinout of industrial conglomerate General Electric (GE), received an undisclosed amount of funding yesterday from Kyoto University’s venturing arm Innovation Capital (Kyoto-iCap).

Funds

Biopharmaceuticals-focused venture firm Forbion Capital Partners has closed its latest fund at $415m, a 44% upgrade on its initial target. The fund’s LPs include insurers ASR Insurances, KLP, the EU-backed European Investment Fund and the German government-owned bank KfW.

Excell Partners, a VC fund affiliated to University of Rochester, is to manage a $25m vehicle intended to spur tech activity around Rochester in upstate New York. The vehicle, dubbed Finger Lakes Forward Venture Capital (FLX) Fund, will be managed by Excell’s Technology Ventures division and funded by the New York State government.

Exits

Funding Circle has gone public in London, in a $576m initial public offering that included $184m of share sales by the online lending platform’s shareholders.

Guardant Health had a health first day as a public company, floating above its range to raise almost $238m in its IPO before seeing its share price rise by 69%.

SurveyMonkey has raised less but had a more successful IPO, floating above its range last week to raise an initial $180m.

Sutro Biopharma, a US-based cancer drug developer based on research at Stanford University and backed by pharmaceutical firms Amgen, Celgene, Eli Lilly and Merck & Co, raised $85m in its initial public offering.

NGM Biopharmaceuticals has filed to raise up to $75m in an initial public offering that will give Merck & Co and Takeda the chance to exit.

On GGV, French solar firm Neoen is aiming for a market capitalisation of €1.5bn ($1.7bn) in an initial public offering (IPO) on the Paris stock exchange.


“Funky Chunk” Kevin MacLeod (incompetech.com)
Licensed under Creative Commons: By Attribution 3.0